These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35291823)

  • 1. Long-Term Secondary Prevention: Management of Blood Pressure After a Transient Ischemic Attack or Stroke.
    McGurgan IJ; Kelly PJ; Turan TN; Rothwell PM
    Stroke; 2022 Apr; 53(4):1085-1103. PubMed ID: 35291823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.
    Boncoraglio GB; Del Giovane C; Tramacere I
    Stroke; 2021 Jun; 52(6):1974-1982. PubMed ID: 33902303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care.
    Fletcher K; Mant J; McManus R; Campbell S; Betts J; Taylor C; Virdee S; Jowett S; Martin U; Greenfield S; Ford G; Freemantle N; Hobbs FD
    BMC Cardiovasc Disord; 2010 Aug; 10():37. PubMed ID: 20696047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.
    Rashid P; Leonardi-Bee J; Bath P
    Stroke; 2003 Nov; 34(11):2741-8. PubMed ID: 14576382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telemedical strategies for the improvement of secondary prevention in patients with cerebrovascular events-A systematic review and meta-analysis.
    Kraft P; Hillmann S; Rücker V; Heuschmann PU
    Int J Stroke; 2017 Aug; 12(6):597-605. PubMed ID: 28440116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering and stroke.
    Saini M; Shuaib A
    Expert Rev Neurother; 2010 Feb; 10(2):225-41. PubMed ID: 20136379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.
    Turner GM; Calvert M; Feltham MG; Ryan R; Fitzmaurice D; Cheng KK; Marshall T
    PLoS Med; 2016 Nov; 13(11):e1002169. PubMed ID: 27846215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does care in a specialised stroke prevention clinic improve poststroke blood pressure control: a protocol for a randomised comparative effectiveness study.
    Sharrief AZ; Hinojosa E; Cooksey G; Okpala MN; Avritscher EB; Pedroza C; Denny MC; Samuels J; Tyson JE; Savitz SI
    BMJ Open; 2019 Feb; 9(2):e024695. PubMed ID: 30782915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
    Zanchetti A; Liu L; Mancia G; Parati G; Grassi G; Stramba-Badiale M; Silani V; Bilo G; Corrao G; Zambon A; Scotti L; Zhang X; Wang H; Zhang Y; Zhang X; Guan TR; Berge E; Redon J; Narkiewicz K; Dominiczak A; Nilsson P; Viigimaa M; Laurent S; Agabiti-Rosei E; Wu Z; Zhu D; Rodicio JL; Ruilope LM; Martell-Claros N; Pinto F; Schmieder RE; Burnier M; Banach M; Cifkova R; Farsang C; Konradi A; Lazareva I; Sirenko Y; Dorobantu M; Postadzhiyan A; Accetto R; Jelakovic B; Lovic D; Manolis AJ; Stylianou P; Erdine S; Dicker D; Wei G; Xu C; Xie H; Coca A; O'Brien J; Ford G
    J Hypertens; 2014 Sep; 32(9):1888-97. PubMed ID: 24979303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.
    Lüders S
    Drugs; 2007; 67(7):955-63. PubMed ID: 17488141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
    Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
    Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
    Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke.
    Webb AJ; Wilson M; Lovett N; Paul N; Fischer U; Rothwell PM
    Stroke; 2014 Oct; 45(10):2967-73. PubMed ID: 25147330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure management for secondary stroke prevention.
    Kitagawa K
    Hypertens Res; 2022 Jun; 45(6):936-943. PubMed ID: 35437312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure-lowering treatment for prevention of recurrent stroke, severe vascular events and dementia in patients with stroke or transient ischemic attack in the past history].
    Heupel-Reuter M; Denkinger M; Bauer JM; Voigt-Radloff S
    Z Gerontol Geriatr; 2019 Mar; 52(2):195-197. PubMed ID: 30868224
    [No Abstract]   [Full Text] [Related]  

  • 16. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.
    Wang Y; Liu M; Pu C
    Int J Stroke; 2017 Apr; 12(3):302-320. PubMed ID: 28381199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
    Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
    Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack.
    Rahman H; Khan SU; Nasir F; Hammad T; Meyer MA; Kaluski E
    Stroke; 2019 Apr; 50(4):947-953. PubMed ID: 30852971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial.
    Geary L; Hasselström J; Carlsson AC; Eriksson I; von Euler M
    Acta Neurol Scand; 2019 Aug; 140(2):107-115. PubMed ID: 31017305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack.
    Brown DL; Levine DA; Albright K; Kapral MK; Leung LY; Reeves MJ; Sico J; Strong B; Whiteley WN;
    Stroke; 2021 Jul; 52(7):e468-e479. PubMed ID: 34024115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.